October 19, 2021
According to the recent research report title ‘United States Pediatric Vaccines Market 2020 – 2027’, available with MarketStudyReport, United States pediatric vaccines market is projected to observe significant growth over 2021-2027, reaching a valuation of USD 15 billion by the end of the forecast period.
As per the report findings, increased government funding for vaccine development, rising awareness about various ailments, and growing vaccine acceptance by the community are fueling United States pediatric vaccines market growth.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2890189/
Moreover, the country observes the very high percentage of children getting vaccinations for various diseases such as diphtheria, tetanus & pertussis (DTaP), measles, mumps & rubella (MMR), and hepatitis B, with polio being one of the most crucial vaccines.
For the uninitiated, pediatric vaccines are those given to children to prevent them from contracting non-infectious and infectious diseases. These vaccinations are viruses that have been heat-killed or inactivated, implying that they have lost their pathogenicity or capacity to cause disease.
The Centers for Disease Control and Prevention's (CDC) regular children immunization programs, inflowing funding, widespread commercial availability of vaccines, and societal awareness of vaccines all contribute to the continued market growth. Rising production of novel vaccines is also driving the market progression.
Citing challenges impacting United States pediatric vaccines market scope, high cost of production is likely to act as a restraint for the industry expansion.
Based on disease indication, the industry is segmented into polio, hepatitis A, hepatitis B, pneumococcal, haemophilus influenzae type B (HIB), diphtheria, tetanus & pertussis (DTaP), measles, mumps & rubella (MMR), rotavirus, varicella / chicken pox, and influenza pediatric.
Of these, pneumococcal segment share is expected to significantly increase over the next six years, owing to the concentration of key players, and established healthcare infrastructure in the economy.
The report further scrutinizes the number of children vaccinated with pediatric vaccines with respect to the aforementioned disease indication. It delivers a conclusive overview of the latest pricing trends, and availability of vaccines in the vertical.
Major companies powering the United States pediatric vaccines industry trends are undertaking strategic acquisitions, launching new products, involving in mergers & acquisitions, as well as expansions to sustain their position in the market.